Cargando…
Management of the ACC/AHA Stage D Patient: Cardiac Transplantation
Over the last 4 decades, cardiac transplantation has become the preferred therapy for select patients with end-stage heart disease. Heart transplantation is indicated in patients with heart failure despite optimal medical and device therapy, manifesting as intractable angina, refractory heart failur...
Autores principales: | Kittleson, Michelle M., Kobashigawa, Jon A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125635/ https://www.ncbi.nlm.nih.gov/pubmed/24286581 http://dx.doi.org/10.1016/j.ccl.2013.09.004 |
Ejemplares similares
-
AHA/ACC/Multisociety Cholesterol Guidelines:
highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019) -
Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017) -
Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines
por: von Knobelsdorff-Brenkenhoff, Florian, et al.
Publicado: (2017) -
The 2017 ACC/AHA stage 1 hypertension is associated with arterial stiffness: a prospective analysis
por: Liu, Shanshan, et al.
Publicado: (2021) -
Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
por: Dong, Yan, et al.
Publicado: (2021)